We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+4.43%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$2.26B
AUM Growth
+$119M
Cap. Flow
+$6.18M
Cap. Flow %
0.27%
Top 10 Hldgs %
23.68%
Holding
567
New
17
Increased
150
Reduced
169
Closed
110

Top Buys

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$4.08M
2
VZ icon
Verizon
VZ
+$3.9M
3
OXY icon
Occidental Petroleum
OXY
+$2.83M
4
ASML icon
ASML
ASML
+$2.77M
5
BA icon
Boeing
BA
+$2.47M

Top Sells

Rank Stock Value
1
VOD icon
Vodafone
VOD
+$2.98M
2
GMED icon
Globus Medical
GMED
+$2.48M
3
NOV icon
NOV
NOV
+$2.12M
4
AGN
Allergan Inc
AGN
+$2.02M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.51M

Sector Composition

Rank Sector Weight
1 Healthcare 16.02%
2 Technology 11.84%
3 Industrials 11.53%
4 Financials 10.85%
5 Consumer Staples 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBM icon
1
IBM
IBM
$198B
$67.5M 2.98%
389,579
+1,039
+0.3% +$187K
XOM icon
2
ExxonMobil
XOM
$629B
$63.7M 2.81%
632,265
-7,044
-1% -$711K
PG icon
3
Procter & Gamble
PG
$345B
$62.8M 2.77%
798,543
-2,936
-0.4% -$237K
JNJ icon
4
Johnson & Johnson
JNJ
$603B
$61.9M 2.73%
591,518
+176
+0% +$17.8K
JPM icon
5
JPMorgan Chase
JPM
$918B
$50.4M 2.22%
874,504
+11,367
+1% +$639K
QCOM icon
6
Qualcomm
QCOM
$183B
$48.9M 2.16%
617,842
-996
-0.2% -$79.2K
SLB icon
7
SLB Ltd
SLB
$69.7B
$47.7M 2.11%
404,401
-2,823
-0.7% -$291K
GE icon
8
GE Aerospace
GE
$353B
$47.3M 2.09%
375,688
+810
+0.2% +$103K
TMO icon
9
Thermo Fisher Scientific
TMO
$195B
$44.4M 1.96%
375,956
-4,160
-1% -$490K
MSFT icon
10
Microsoft
MSFT
$2.95T
$41.9M 1.85%
1,004,303
+2,761
+0.3% +$112K
AXP icon
11
American Express
AXP
$239B
$41M 1.81%
432,172
-4,316
-1% -$389K
RTX icon
12
RTX Corp
RTX
$261B
$40.6M 1.79%
558,851
+6,553
+1% +$483K
PEP icon
13
PepsiCo
PEP
$184B
$40.5M 1.79%
453,172
+1,532
+0.3% +$132K
CELG
14
DELISTED
Celgene Corp
CELG
$39.8M 1.76%
463,090
-3,294
-0.7% -$250K
MCD icon
15
McDonald's
MCD
$188B
$39.7M 1.75%
394,301
+3,257
+0.8% +$329K
DIS icon
16
Walt Disney
DIS
$167B
$33.5M 1.48%
390,780
+2,361
+0.6% +$193K
CVX icon
17
Chevron
CVX
$381B
$31.9M 1.41%
244,623
+12,170
+5% +$1.51M
CMCSK
18
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$30M 1.33%
563,029
+10,102
+2% +$539K
AAPL icon
19
Apple
AAPL
$4.81T
$29.9M 1.32%
1,286,856
+14,872
+1% +$316K
KO icon
20
Coca-Cola
KO
$353B
$25.6M 1.13%
604,112
+10,680
+2% +$433K
NVS icon
21
Novartis
NVS
$294B
$25.6M 1.13%
315,202
+983
+0.3% +$77.3K
OXY icon
22
Occidental Petroleum
OXY
$56.2B
$23.3M 1.03%
236,502
+30,079
+15% +$2.83M
SBUX icon
23
Starbucks
SBUX
$119B
$22.6M 1%
583,688
-7,128
-1% -$259K
NOV icon
24
NOV
NOV
$7.25B
$21.5M 0.95%
260,595
-28,494
-10% -$2.12M
KRFT
25
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$21.3M 0.94%
354,849
+5,826
+2% +$337K

Similar funds

Gofen & Glossberg's Q2 2014 Portfolio in Review

As of Q2 2014, Gofen & Glossberg held 567 positions worth $2.26B, up 5.5% from $2.15B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Gofen & Glossberg's Q2 2014 filing shows 17 new, 150 increased, 169 reduced and 110 closed positions. Its largest new stake was Splunk Inc: 35,720 shares worth $1.98M. The largest sale was Vodafone, an estimated $2.98M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Industrials.

  • Gofen & Glossberg's largest Q2 2014 buy was Splunk Inc: 35,720 shares worth $1.98M.
  • Gofen & Glossberg added most to Perrigo in Q2 2014, an estimated $4.08M increase.
  • Gofen & Glossberg's biggest Q2 2014 reduction was Vodafone, cutting an estimated $2.98M.
  • Gofen & Glossberg fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $722K.
  • Gofen & Glossberg's ten largest holdings make up 24% of its $2.26B portfolio in Q2 2014.
  • Gofen & Glossberg opened 17 new positions and closed 110 in Q2 2014.
  • Gofen & Glossberg's portfolio value rose 5.5% quarter-over-quarter to $2.26B.

Based on Gofen & Glossberg's 13F filing for Q2 2014, filed 15 Jul 2014.